Myanmar Pharmaceuticals and Healthcare Report

 Published On: Jun, 2016 |    No of Pages: 53 |  Published By: BMI Pharmaceuticals and Healthcare | Format: PDF
Request Free Sample
BMI View: The frontier Myanmar pharmaceuticals and healthcare market boasts high potential and is poised to see significant reforms over the coming years, although in the near term it will remain a high-riskventure for most multinational drug makers given prevailing economic and political risks. The country's attractiveness will be boosted over the long term by the development of its intellectual property protection environment and its nascent health insurance sector - areas that the Myamar government has taken positivesteps towards improving.

Headline Expenditure Projections
- Pharmaceutical sales: MMK458.3bn (USD390mn) in 2015 to MMK535.3bn (USD410mn) in 2015;+16.8% in local currency terms and +3.9% in US dollar terms. Forecast broadly in line with previousquarter.
- Healthcare Expenditure: MMK1,579.9bn (USD1.36bn) in 2015 to MMK1,755.1bn (USD1.34bn) in2016; +11.1% in local currency terms and -1.2% in US dollar terms. Absolute figures revised upwardsfrom previous quarter. However, growth forecast remains broadly unchanged.
BMI Industry View ... 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Myanmar 2014-2020) . . 7
SWOT ...... 9
Industry Forecast .. 10
Pharmaceutical Market Forecast .... 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Myanmar 2012-2020) . . . . 12
Healthcare Market Forecast . 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) . . . . 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) . . . 16
Pharmaceutical Trade Forecast ..... 17
Table: Pharmaceutical Trade Data And Forecasts (Myanmar 2014-2020) . . . 18
Table: Pharmaceutical Trade Data And Forecasts local currency (Myanmar 2014-2020) . . . . . 18
Industry Risk Reward Index ... 19
Asia Pacific Risk/Reward Index - Q3 2016 . 19
Myanmar Risk/Reward Index 25
Rewards ........ 25
Risks .... 25
Regulatory Review 27
Market Overview ... 29
Healthcare Sector .... 29
Research & Development ... 31
Clinical Trials 31
Epidemiology . 31
Communicable Diseases And Other Injuries ...... 32
Non-Communicable Diseases ....... 32
Competitive Landscape . 34
Table: Multinational Market Activity . 35
Company Profile .... 36
Fame Pharmaceutical 36
Mega Lifesciences ..... 38
Demographic Forecast .. 42
Table: Population Headline Indicators (Myanmar 1990-2025) . . . . 43
Table: Key Population Ratios (Myanmar 1990-2025) . . 43
Table: Urban/Rural Population & Life Expectancy (Myanmar 1990-2025) . . . 44
Table: Population By Age Group (Myanmar 1990-2025) . . . . 44
Table: Population By Age Group % (Myanmar 1990-2025) . 45
Glossary ........ 47
Methodology . 49
Pharmaceutical Expenditure Forecast Model .... 49
Healthcare Expenditure Forecast Model .. 49
Notes On Methodology ....... 50
Risk/Reward Index Methodology ... 51
Index Overview ........ 52
Table: Pharmaceutical Risk/Reward Index Indicators . 52
Indicator Weightings 53
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.